Cost-effectiveness analysis of hepatitis A prevention in travellers

The advent of new vaccines and the changing epidemiology of hepatitis A call for an update of the economic evaluation of costs and benefits associated with the various alternative preventative strategies. A decision-tree-based model has been developed which enables the calculation of expected costs...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Vaccine 1992, Vol.10, p.S88-S92
Hauptverfasser:	Tormans, Guy, Van Damme, Pierre, Van Doorslaer, Eddy
Format:	Artikel
Sprache:	eng
Schlagworte:	Biological and medical sciences Cost-Benefit Analysis cost-effectiveness analysis Decision Trees Fundamental and applied biological sciences. Psychology Hepatitis A Hepatitis A - economics Hepatitis A - prevention & control Hepatitis A - therapy Hepatitis A Vaccines Hepatovirus - immunology Humans Immunization, Passive Immunology Life Sciences & Biomedicine Medicine, Research & Experimental Microbiology Prevalence Research & Experimental Medicine Science & Technology Travel Vaccination Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies Viral Hepatitis Vaccines Virology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!